Delayed presentation in posterior urethral valve: long-term implications and outcome

M S Ansari1, Pratipal Singh, Anil Mandhani

  • 1Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. ansarimsa@hotmail.com

Urology
|March 1, 2008
PubMed

Insights

Delayed presentation of posterior urethral valves (PUV) in children over 2 years old is associated with higher risks of azotaemia and chronic renal insufficiency. Early diagnosis and intervention are crucial for better long-term outcomes in PUV patients.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Outcomes

Background:

  • Posterior urethral valves (PUV) are a common congenital anomaly in male infants.
  • Delayed diagnosis of PUV can lead to significant renal damage and long-term complications.

Purpose of the Study:

  • To analyze the impact of delayed presentation of posterior urethral valves on long-term outcomes in children.
  • To identify prognostic factors for children with PUV.

Main Methods:

  • A retrospective analysis of 194 children with PUV who underwent surgical ablation.
  • Patients were divided into two groups based on age at presentation: Group I (<2 years) and Group II (>2 years).
  • Data on presenting complaints, azotemia, serum creatinine, surgical outcomes, and long-term renal function were analyzed.

Main Results:

  • Group II (late presenters) showed significantly higher rates of azotemia (81.8% vs 32.6%) and higher mean serum creatinine levels compared to Group I.
  • Voiding improvement after ablation was significantly lower in Group II (20.4% vs 86.1%).
  • Long-term renal insufficiency developed in 40.8% of Group II patients versus 30.5% of Group I patients.

Conclusions:

  • Delayed presentation of PUV beyond 2 years of age is associated with poorer outcomes, including a higher risk of chronic renal insufficiency.
  • Serum creatinine levels at presentation and 1 year post-ablation, along with persistent VUR and voiding dysfunction, are key prognostic indicators.
  • Pediatric patients with PUV presenting after 2 years require cautious management due to increased risks.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...